Odyssey Health (ODYY) Income from Continuing Operations (2014 - 2026)
Odyssey Health (ODYY) posted quarterly Income from Continuing Operations of 825105.0 for Q2 2026, down 333.24% year-over-year from 353758.39 in Q2 2025, and down 38.82% quarter-over-quarter from 594371.0 in Q1 2026.
Odyssey Health (ODYY) Income from Continuing Operations (2014 - 2026) Analysis & Trends
Odyssey Health's Income from Continuing Operations history runs 13 years deep, the most recent figure standing at 825105.0 for Q2 2026.
- In Q2 2026, Income from Continuing Operations fell 333.24% year-over-year to 825105.0; the TTM figure through Apr 2026 stood at 2032585.0 (down 124.59% YoY), while the FY2025 annual figure was 1273269.0, up 52.1% from the prior year.
- Income from Continuing Operations for Q2 2026 stood at 825105.0, down from 594371.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 153644.0 in Q3 2024, with the low at 3099222.0 in Q2 2022.
- The 5-year median for Income from Continuing Operations is 731246.0 (2023), against an average of 979872.17.
- The sharpest annual moves came in 2024 and 2026: Income from Continuing Operations surged 118.87% in 2024, then tumbled 333.24% in 2026.
- Odyssey Health's Income from Continuing Operations stood at 2149106.0 in 2022, then surged by 74.96% to 538100.0 in 2023, then decreased by 20.46% to 648208.0 in 2024, then surged by 38.52% to 398526.0 in 2025, then tumbled by 107.04% to 825105.0 in 2026.
- Business Quant data shows ODYY's Income from Continuing Operations at 825105.0 in Q2 2026, 594371.0 in Q1 2026, and 398526.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Odyssey Health | 1.01 Mn | 711,880.61 | - | -825,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -825,105.00 |
| Jan 31, 2026 | -594,371.00 |
| Oct 31, 2025 | -398,526.00 |
| Jul 31, 2025 | -214,583.00 |
| Apr 30, 2025 | -190,450.00 |
| Jan 31, 2025 | -220,024.00 |
| Oct 31, 2024 | -648,208.00 |
| Jul 31, 2024 | 153,644.00 |
| Apr 30, 2024 | -474,598.00 |
| Jan 31, 2024 | -1.30 Mn |
| Oct 31, 2023 | -538,100.00 |
| Jul 31, 2023 | -814,284.00 |
| Apr 30, 2023 | -1.28 Mn |
| Jan 31, 2023 | -1.68 Mn |
| Oct 31, 2022 | -2.15 Mn |
| Jul 31, 2022 | -1.18 Mn |
| Apr 30, 2022 | -3.10 Mn |
| Jan 31, 2022 | -2.18 Mn |
| Oct 31, 2021 | -1.65 Mn |
| Jul 31, 2021 | -2.58 Mn |